Meta-research metrics matter: letter regarding article “indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease”

[1]  G. Duarte,et al.  Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins? , 2017, Movement disorders clinical practice.

[2]  D. Claassen,et al.  Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease , 2017, Journal of Clinical Movement Disorders.

[3]  Jane S. Paulsen,et al.  Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial. , 2016, JAMA.

[4]  Morgen M. Miller,et al.  Rank reversal in indirect comparisons. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  G. Guyatt,et al.  GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. , 2011, Journal of clinical epidemiology.

[6]  Aman A. Savani,et al.  Practice Advisory: Utility of surgical decompression for treatment of diabetic neuropathy: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology , 2007, Neurology.

[7]  Jonathan J Deeks,et al.  Issues in the selection of a summary statistic for meta‐analysis of clinical trials with binary outcomes , 2002, Statistics in medicine.

[8]  S D Walter,et al.  Choice of effect measure for epidemiological data. , 2000, Journal of clinical epidemiology.

[9]  I Olkin,et al.  Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. , 2000, Statistics in medicine.

[10]  S D Walter,et al.  The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. , 1997, Journal of clinical epidemiology.